NCT06816121View on ClinicalTrials.gov

Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions

Lung Cancers

All Listed Sponsors

lead

Everest Detection, Inc.

INDUSTRY